Clinical Commentary: Obstetric and Respiratory Management of Pregnancy with Severe Spinal Muscular Atrophy by Flunt, Daniel et al.
Hindawi Publishing Corporation
Obstetrics and Gynecology International
Volume 2009, Article ID 942301, 5 pages
doi:10.1155/2009/942301
Case Report
ClinicalCommentary: Obstetric and Respiratory Management of
Pregnancy with Severe Spinal Muscular Atrophy
DanielFlunt,1 Natasha Andreadis,2 Collette Menadue,1 andAl ecW .W el sh 3
1Department of Respiratory and Sleep Medicine, The Royal Prince Alfred Hospital, Missenden Road, Camperdown,
NSW 2050, Australia
2Department of Obstetrics and Gynaecology, The Royal Prince Alfred Hospital, Missenden Road, Camperdown, NSW 2050, Australia
3Department of Maternal-Fetal Medicine, The Royal Hospital for Women, University of New South Wales, Barker Street, Randwick,
NSW 2031, Australia
Correspondence should be addressed to Alec W. Welsh, alec.welsh@unsw.edu.au
Received 19 September 2008; Revised 15 December 2008; Accepted 9 March 2009
Recommended by Ellen W. Freeman
We present a combined obstetric and respiratory perspective on two pregnancies for a woman with severe Type 2 Spinal Muscular
Atrophy (SMA). Our patient had the lowest prepregnancy weight (20kg) and vital capacity of 0.34L (VC 11% predicted) yet
to be reported in the sparse literature on pregnancy with SMA. She delivered two live healthy infants via planned caesarean
section without pregnancy or neonatal complication. We describe the respiratory and obstetric management techniques used
for a pregnancy with this degree of respiratory compromise.
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1.Introduction
Spinal Muscular Atrophy (SMA) has an incidence of 1/6000–
1/10000 and a carrier frequency of 1/40 to 1/50 [1], being the
second commonest autosomal recessive disorder in whites
after cystic ﬁbrosis [2]. It is characterized by degeneration
of alpha neurons in the anterior horn cells of the spinal
cord leading to progressive muscle atrophy and premature
death, usually from respiratory failure. Type 1 SMA (the
most severe) presents with weakness at birth or in the
ﬁrst six months of life. Type 2 SMA presents between
six and 18 months of age with weakness of muscles in
the legs and trunk and failure to meet motor milestones
(crawlingandwalking).Prognosisisdependentontheextent
and timing of respiratory complications. Inspiratory muscle
weakness predisposes the individual to ventilatory failure,
and expiratory muscle impairment causes an ineﬀective
cough, which can lead to secretion retention and chronic
atelectasis [3]. Type 3 SMA presents after 18 months
of age with the ability to walk which may be lost in
time.
We report two successful pregnancies in a woman
with Type 2 SMA, with a vital capacity (VC) of 0.34L
(11% of predicted value [4]) and baseline inspiratory and
expiratory muscle strengths of −27cmH2O (41% predicted)
and +19cmH2O (22% predicted), respectively. Successful
pregnancies in patients with Type 2 SMA have been reported
previously but at baseline vital capacities of 0.6 to 1.98L
[5, 6] and percent predicted values of 30 to 67% [7–9].
Pregnancy has also been reported in a tracheostomised
patient with Type 1 SMA (VC 0.47L) [10] and in three
postpoliomyelitis patients, continuously dependent on non-
invasive ventilation (NIV), with vital capacities as low as
0.24L to 0.28L [11]. Our case highlights the importance
of multidisciplinary antenatal care in managing such a
condition during pregnancy and in achieving the optimal
outcome for both mother and baby.
2.CaseReport
A 32-year-old woman presented to a high-risk pregnancy
clinic in her ﬁrst ongoing pregnancy. Developmentally,
her milestones had been classically delayed, crawling at
age one. She slowly developed severe contractures of her
limbs and severe kyphoscoliosis throughout her teenage2 Obstetrics and Gynecology International
years. At age 17, she presented with compensated hyper-
capnic respiratory failure (pH 7.41, PaCO2 57mmHg, PaO2
48mmHg, bicarbonate 36mmol/L) and was commenced
on nocturnal nasal assist-control volume ventilation for
ventilatory insuﬃciency. Her daytime arterial blood gases
(ABGs) normalized and stabilized with continued nocturnal
NIV usage. She was above average in performance at school
and completed a university degree. Diagnosis of Type 2 SMA
with a homozygous deletion of the SMN 1 gene had been
made at age 23.
2.1. 1st Pregnancy. Antenatal booking weight was 20 kilo-
grams, and the patient was wheelchair dependent and kept
uprightb ymeansofaneckbrac e,withmo v ementonlyofher
left wrist and left ﬁngers. Clexane thromboprophylaxis was
commenced given her immobility (10mg daily). The couple
declined invasive genetic testing for SMA. First trimester
screening gave a risk of approximately 1 : 2000 for Trisomy
21.
Outpatient respiratory monitoring was performed every
second week from week 10 to 22, then weekly from week 22
to 26, including VC and peak cough ﬂow rates. Sequential
inspiratory and expiratory muscle strength measurement
wereattempted,butthepatientdidnothavesigniﬁcanteﬀort
to register a measurement consistently. Baseline (10 weeks)
ABGs were attempted, but abandoned due to the diﬃculty in
obtaining a sample secondary to severe contractures in her
wrists, elbows, and hips. For this reason, routine serial ABGs
were not performed and due to a lack of equipment, end-
tidal CO2 measures were not obtained. Room air oximetry
served as a guide to gas exchange during her pregnancy,
and ABGs measurements would have been performed in
conjunction with deterioration in respiratory symptoms.
Using the patient’s own volume ventilator (VS Ultra,
SAIME, Savigny le Temple, France; tidal volume 0.35L, rate
22, inspiratory time 1.1s), a mouthpiece (Hudson RCI,
Temecula, Calif, USA) was introduced and she was shown
how to “breath stack” thrice daily, to achieve maximal insuf-
ﬂation capacity and as a convenient method to supplement
tidal breathing when awake. Training on the mechanical
inexsuﬄator (CoughAssist, Respironics, Murrysville, Pa,
USA) and manual assisted coughing was regularly practised
as a precaution for secretion retention, with particular
emphasisbeingplacedontheimportanceofthesetechniques
for the postoperative period. A variety of mask interfaces
(including mouthpiece) were trialled to minimise potential
pressure trauma to the nose and face from her usual nasal
mask (Non-vented Sullivan-Bubble-Mask, ResMed, Sydney,
Australia),incasesheprogressedtodiurnalventilatordepen-
dence. Signiﬁcant respiratory compromise was anticipated.
However, the timing and rate of respiratory deterioration
were unable to be determined as domiciliary monitoring
equipment such as a pulse oximeter, and devices such as a
mechanical inexsuﬄator were not provided by the patient’s
health care system.
Respiratory function remained stable during the preg-
nancy, with VC ranging between 0.22 to 0.30L and SpO2 on
room air from 93 to 97%, as illustrated in Figure 1(a).P e a k
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(a) First pregnancy: week from gestation versus vital capacity and
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(b) Second pregnancy: week from gestation versus vital capacity and
SpO2
Figure 1: Vital capacity (VC) (solid line) and room air oxygen
saturations (SpO2) (dashed line) measured at week from gestation
for (a) the ﬁrst and (b) the second pregnancies.
cough ﬂow rates during the pregnancy ranged between 0.74
and 1.2L/s. Ultrasonography at 24 weeks, 5 days showed an
appropriately grown fetus weighing 0.629kg (60th centile)
with no evidence of compromise.
Planned admission took place at 26 weeks gestation for
daily respiratory observation and preparation for delivery
by planned caesarean section at 28 weeks. The indication
for mode of delivery was a combination of prematurity,
kyphoscoliosis, anticipated cephalopelvicdisproportion, and
primiparity. The gestation was chosen as the best balance of
fetal respiratory maturity and maternal respiratory function,Obstetrics and Gynecology International 3
anthropometry, home equipment constraints, and patient’s
preference for level of NIV dependency. Respiratory status
was stable with SpO2 96% on room air, respiratory rate
(RR) of 26breaths/min and VC 0.26L. Antenatal admission
allowed multidisciplinary review by anaesthetists, inten-
sivists, neonatologists, midwives, physiotherapists, dieti-
cians, occupational therapists, lactation consultants, and
social workers. Respiratory function remained stable with
the use of nocturnal NIV, with only transient complaints of
dyspnoea on repositioning relieved by short bouts of day-
time nasal ventilation. Preoperative VC measured 0.26L and
weight was 23.5kg (BMI 9.6kg/m2). Two doses of 11.4mg
betamethasone acetate were administered one week prior to
delivery for fetal lung maturation.
At caesarean section, epidural space cannulation was
successful yet the sensory block was unsatisfactory for the
level of surgery, potentially due to a partial occlusion of
the epidural space related to her severe kyphoscoliosis.
Consequently, a general anaesthetic was administered with
the assistance of mouthpiece volume ventilation to assist
breathing during the awake ﬁbre-optic nasal intubation.
During the process of the intubation, supplemental oxygen
was not required to be entrained through the mouthpiece
ventilation, as transient falls in saturations were caused by
suboptimal ventilation which occurred when the mouth
piece seal was lost during moments of anxiety. This was
instead corrected by manually assisting with the patient’s
mouthpiece seal, promoting calm in the patient and by
increasing the volume being delivered by the ventilator
(from 0.35 to 0.45L) to cope with transient leaks. A
midline abdominal incision was performed for access due
to the kyphoscoliosis, with minimal subcutaneous fat and
an atrophied rectus abdominis muscle being noted. An
uneventful lower segment caesarean section was performed
with delivery of a live female infant (Apgars of 7 at 1 minute,
9a t5m i n u t e s ,b i r t hw e i g h t1 . 0 5 4k g ) .
The patient was transferred to the intensive care unit
(ICU) and extubated directly onto her noninvasive ventilator
four hours later. Postnatally, respiratory function remained
stable with room air SpO2 96% and RR 24. She was
transferred to the postnatal ward three days later, where
she continued to express breast milk and had daily chest
physiotherapy which consisted of insuﬄation via her volume
ventilator with manual assisted coughing. As an abdominal
thrustwasinappropriatesecondarytotheabdominalwound,
a ptussive squeeze was utilised. Mechanical inexsuﬄation
was not required. She was discharged from hospital 10 days
after delivery whilst her baby remained well in the neonatal
ICU. Postoperative VC was measured at 0.21 to 0.23L and
was most likely pain limited. The neonate was transferred to
a level 2 nursery at another hospital closer to the couple’s
home at a corrected age of 32 weeks. Three and a half
months following discharge, the mother’s VC had returned
to 0.33L, and review by a neonatologist found the infant
to be developing normally. The child’s weight (3.5kg) and
head circumference (35.5cm) were increasing appropriately
around the 10th percentile. The couple was happy to have
the newborn monitored clinically for any signs of SMA and
declined genetic testing.
2.2. 2nd Pregnancy. An unplanned second pregnancy was
conﬁrmed eight months later, with late presentation at 19
weeksgestation.Betweenpregnancies,therehadbeenfurther
deterioration in the patient’s neuromuscular condition, with
loss of left hand function removing control of her electric
wheelchair. On ﬁrst presentation, VC had fallen to 0.27L
(8% predicted). The antenatal care plan was duplicated
between pregnancies. Respiratory function remained stable
during the pregnancy (VC 0.24 to 0.32L and SpO2 94
to 98%), requiring only nocturnal nasal ventilation. These
measurements are illustrated in Figure 1(b). Admission took
place at 26 weeks for respiratory optimization, with VC at
surgery being 0.28L.
At 28 weeks and after steroid cover, an elective classical
caesarean section with bilateral tubal sterilization (at the
patient’s request) was performed through the previous
vertical abdominal midline incision. An elective awake
mouthpiece-assisted ﬁbreoptic intubation general anaes-
thetic was performed. A live, male infant was delivered
( A p g a r so f6a t1m i n u t e ,7a t5m i n u t e s ,8a t1 0m i n u t e s ,
birth weight 1kg). Postoperatively, the patient was admitted
to ICU, where she was extubated on to NIV three hours
later and discharged to the obstetric ward two days later.
During this time there was a minor increase in sputum
which was coughed out eﬀectively after volume ventilator
insuﬄation and using manual assist techniques (ptussive
squeeze). Oxygen saturations on room air remained ≥96%
throughout her recovery period. Postpartum course was
uneventful, and discharge took place on day seven.
3. Discussion
Innormalpregnancies,totallungcapacityispreservedwitha
small reduction in residual volume which generally stabilises
or mildly enhances the VC. The major change in normal
lung volumes is the reduction in functional residual capacity
due to a reduction in chest wall compliance, starting early
second trimester and worsening as the pregnancy progresses
to a 35% to 40% decline [12]. In our patient it was felt that
this could promote further microatelectasis and impede her
ability to generate adequate tidal volumes.
For ongoing SMA pregnancies, antenatal care centres
around maternal respiratory function, with NIV being
shown to reduce respiratory compromise [10] as shown
here. The beneﬁts of training breath stacking to maximal
insuﬄation have been described as important in preventing
continued microatelectasis from chronically underventilated
lungs and by maintaining the patients’ chest wall range
of motion to prevent further deterioration in VC [13].
Insuﬄation can be achieved eﬀectively using a volume
ventilator or a manual resuscitation bag and a one-way valve
[13, 14]. Increase in insuﬄation capacity has been associated
with the ability to generate more eﬀective peak cough ﬂows
[13]. Manually assisted coughing [15, 16] and mechanical
in-exsuﬄation [16] further enhance peak cough ﬂows. In
one study, the addition of insuﬄation capacity to unassisted
inspiration in neuromuscular patients increased peak cough
ﬂows from 1.81L/s to 3.37L/s. Furthermore, adding manual4 Obstetrics and Gynecology International
abdominalassistanceresultedinpeakcoughﬂowsof4.27L/s,
and mechanical in-exsuﬄation increased peak cough ﬂows
to 7.47L/s [16]. In our patient where a growing uterus would
put an increased load on her already small, stiﬀ,a n dw e a k
chest wall, it was paramount to try to maintain the patient’s
pulmonary compliance by breath stacking and to have
practised techniques (including mechanical in-exsuﬄation)
to promote early and successful extubation and eﬀective
secretion removal [17]. This was of special concern as her
peak cough ﬂows were well below the suggested threshold
of 2.7L/s [17]f o re ﬀective airway clearance. However,
mechanical inexsuﬄation was not utilised for this patient, as
eﬀective secretion clearance was achieved with insuﬄation
and manual assisted coughing alone, and this method was
preferred by the patient. In addition to the volume ventilator
assisting with mouthpiece ventilation and breath stacking, it
also ensures that a consistent tidal volume is delivered to the
patient in the presence of changing respiratory compliance
or resistance [18]. In contrast, with pressure preset devices
(e.g., bi-level positive airway pressure) the patient cannot
breath stack and tidal volumes delivered will vary based
on changes in respiratory mechanics, likely to occur as
pregnancy progresses.
The importance of avoiding routine mask-oxygen pre-
scription (without mechanical ventilation) in patients who
are desaturating due to alveolar hypoventilation should be
emphasized. In these scenarios supplemental oxygen alone
can lead to reduced ventilatory drive, CO2 retention, and
respiratory failure. It is for this reason that mechanical
ventilation(usuallyNIV)istheprimarytreatmentoptionfor
hypoventilation in neuromuscular disease [19, 20].
In order to assess the adequacy of ventilation, a measure
of CO2 should be undertaken. ABGs provide the most
accuratemeasure,butduetothediﬃcultyinobtainingblood
in this patient, routine measurements were not performed.
As there were no signs of sustained deterioration on room
air, obtaining such a sample was not pursued. However,
in retrospect CO2 should have been monitored routinely.
Other accurate measures include arterial capillary sampling
from the ear lobe or ﬁnger pulp [21], arterialised venous
sampling [22] ,a n ds e r i a lm e a s u r e so fs e r u mb i c a r b o n a t e .
Careful interpretation is required as “normal” pregnancy
baselinebicarbonatelevelsarelowerat15to20mmol/L[12].
End-Tidal CO2 monitoring is a noninvasive measure which
has been shown to correlate with PaCO2 in nonintubated
patients breathing room air [23, 24]. However, the proximity
of this relationship declines in the presence of ventilation-
perfusion mismatching [24]. Transcutaneous CO2 is a less
reliable measure and can over or under estimate PaCO2
results in adults [25].
During the outpatient period, SpO2 levels were mea-
sured weekly at one or two intervals. At this frequency of
monitoring, a detection of respiratory deterioration may
have been missed or delayed. In patients with access to
domiciliaryoximetry,actingonSpO2 <95%withmechanical
in-exsuﬄation and increasing use of NIV can signiﬁcantly
decrease hospitalization rates for respiratory complications
of neuromuscular disease [26]. Our patient presented with a
baseline SpO2 of 96% and a range from 93 to 97%. At times
when her SpO2 was abnormal (i.e., below 95%) a measure of
CO2 would have assisted to clarify whether hypercapnia was
present. Hypercapnia would likely indicate hypoventilation
or secretion retention, both of which can be ameliorated
by increasing NIV assistance and mechanical in-exsuﬄation
[26].
Obstetric care during this pregnancy revolved around
close regular obstetric surveillance, ongoing respiratory
team review, admission for intensive observation, and a
multidisciplinary decision regarding the optimum gestation
for delivery. The latter decision is most likely to be open
to discussion. In the absence of published literature on the
precise eﬀects of advancing gestation in a woman with Type
2 SMA weighing just 20kg and with a VC of 11% predicted,
it was diﬃcult to be certain how much further incapacitation
could be withstood before the mother’s respiratory status
was put at risk. Whilst it is feasible to provide continuous
ventilatory support via daytime mouthpiece ventilation and
nocturnal mask ventilation in patients with very low VC
throughout pregnancy [11], our patient stated that she did
not wish to use NIV support continuously. Management and
delivery was therefore a balance of neonatal versus maternal
mortality and morbidity, as is frequently the case in perinatal
management. There is no literature on maternal outcome
with such poor respiratory function and low pregnancy
weight in SMA, though a limited amount of literature
exists for other causes of respiratory compromise [11, 27,
28].
Anaesthetic review prior to labour and delivery is
essential due to the respiratory compromise in SMA and
the associated diﬃculties with both regional and general
anaesthesia. Failed regional anaesthesia due to spinal column
deformity is not uncommon in SMA, and the usefulness
of subsequent awake ﬁbreoptic technique has been reported
[29]. General anaesthesia may be hazardous due to restric-
tion in mouth opening, sensitivity to muscle relaxants,
and hyperkalaemia postadministration of suxamethonium.
Whilst caesarean section is the most common mode of
delivery in SMA, women with more minor forms of this
condition have adequate uterine function and can achieve
av a g i n a ld e l i v e r y .P r e v i o u sc a s er e p o r t sh a v ed o c u m e n t e d
a caesarean section for cephalopelvic disproportion at full
dilatation after the spontaneous onset of labour, and an
induction of labour at 37 weeks gestation with delivery by
vacuum extraction, in women with Type 3 SMA with no
respiratory compromise [30].
A literature review was performed by searching MED-
LINE from 1950 to August 2008 using key words “spinal
muscular atrophy”, “SMA,” and “pregnancy”. Seventeen case
reports describing a total of 33 pregnancies were identiﬁed.
The largest review was of 12 females with 17 infants [2]. Ges-
tation at delivery of these women with more minor degrees
of SMA ranged from 31–39 weeks. From our experience and
the published literature, pregnancy in women with SMA can
be successful despite potential complications. These women
should obtain prepregnancy advice and antenatal care from
a multidisciplinary team of healthcare professionals, in order
to maximise outcomes for mother and baby and achieve
informed consent.Obstetrics and Gynecology International 5
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